Clinical Trials Browser

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms, Neoplasms by Histologic Type, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT01108445 2018-01-16

ASPEN

Phase 2 Completed

131 enrolled 21 charts

Genitourinary

Kidney Neoplasms, Neoplasms

NCT01784978 2017-10-02

SUNRISES

Phase 2 Terminated

41 enrolled

Genitourinary

Margins of Excision, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

NCT01064310 2017-04-17

PISCES

Phase 3 Completed

169 enrolled 16 charts

Genitourinary

Carcinoma, Renal Cell, Neoplasms, Patient Preference

NCT00617253 2017-03-01

Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients

Phase 2 Completed

9 enrolled

Genitourinary

Carcinoma, Renal Cell, Neoplasms

NCT00980213 2014-02-06

Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

Completed

80 enrolled

Genitourinary

Carcinoma, Renal Cell, Neoplasms

Clinical Trials

JAVELIN Renal 101

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma

ASPEN

SUNRISES

PISCES

Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients

Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland